Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

210

HTML

1595

Tables (1-2)

127

Sum=1932

Apr 21, 2005 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Apr 21, 2005; 11(15): 2334-2336
Published online Apr 21, 2005. doi: 10.3748/wjg.v11.i15.2334

Table 1 Influence of various PPIs on intestinal metaplasia in the noneradicated Helicobacter pylori infection patients.

χ² = 2.462, γ = 3, P = 0.4821.

Table 2 Influence of various PPIs on intestinal metaplasia in the eradicated Helicobacter pylori infection patients.

χ² = 2.702, γ = 3, P = 0.4388.

Citation: Marusic M, Babic Z, Nesanovic M, Lucijanic-Mlinac M, Stajcar V. Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients. World J Gastroenterol 2005; 11(15): 2334-2336
URL: https://www.wjgnet.com/1007-9327/full/v11/i15/2334.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i15.2334